Guillermo Gervasini
Department of Pharmacology
Medical School
University of Extremadura
Badajoz
Spain
Name/email consistency: high
- GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high-incidence area. Gervasini, G., San Jose, C., Carrillo, J.A., Benitez, J., Cabanillas, A. Nutr. Cancer (2010)
- CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk. Gervasini, G., de Murillo, S.G., Ladero, J.M., Agúndez, J.A. Pharmacogenomics (2010)
- Polymorphisms in methotrexate pathways: what is clinically relevant, what is not, and what is promising. Gervasini, G. Curr. Drug Metab. (2009)
- Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients. Gervasini, G., García-Martín, E., Ladero, J.M., Pizarro, R., Sastre, J., Martínez, C., García, M., Diaz-Rubio, M., Agúndez, J.A. BMC. Cancer (2007)
- Effect of neurotransmitters on NADPH-cytochrome P450 reductase in vitro activity. Gervasini, G., Martinez, C., Benitez, J., Agúndez, J.A. Drug. Metab. Lett (2007)
- The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study. Gervasini, G., Vizcaino, S., Carrillo, J.A., Caballero, M.J., Benitez, J. Br. J. Clin. Pharmacol (2006)
- Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Gervasini, G., Carrillo, J.A., Garcia, M., San Jose, C., Cabanillas, A., Benitez, J. Cancer (2006)
- Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations. Gervasini, G., Vizcaino, S., Gasiba, C., Carrillo, J.A., Benitez, J. Ther. Drug. Monit (2005)